insidehealthpolicy.com

Evaluation du site insidehealthpolicy.com

InsideHealthPolicy.com | An Inside Washington news service

 Généré le 13 Mars 2026 11:01

Vieilles statistiques? UPDATE !

Le score est de 60/100

Optimisation du contenu

Titre

InsideHealthPolicy.com | An Inside Washington news service

Longueur : 58

Parfait, votre titre contient entre 10 et 70 caractères.

Description

InsideHealthPolicy is a subscription-based news service on the evolving debate over federal health-care policy reforms and spending.

Longueur : 132

Génial, votre balise META description contient entre 70 et 160 caractères.

Mots-clefs

Très mauvais. Nous n'avons pas trouvé de balise META keywords sur votre page. Utilisez ce générateur gratuit de balises META en ligne pour créer des mots-clés.

Propriétés Open Graph

Cette page ne profite pas des balises META Open Graph. Cette balise permet de représenter de manière riche n'importe quelle page dans le graph social (environnement social). Utilisez ce générateur gratuit de balises META Open Graph pour les créer.

Niveaux de titre

H1 H2 H3 H4 H5 H6
5 26 0 0 0 0
  • [H1] Home
  • [H1]
  • [H1] Trump Admin To Launch Tariff Probe Into Foreign Drug Pricing Policies In Coming Months
  • [H1] Oz Wants Agentic AI Tools For All Medicare Beneficiaries
  • [H1] CMS To Make $50 Zepound, Wegovy Available Before BALANCE Launch
  • [H2] Login
  • [H2] Exclusive, reliable health policy reporting, just when it matters most. Now is the time to try Inside Health Policy.
  • [H2] Sign up for 30 days of free access.
  • [H2] Breaking News
  • [H2] MAHA Memo Signals Strategic Retooling On Vaccine Messaging Ahead Of Midterms  
  • [H2] CCIIO Chief Says Fraud Crackdown Removed 1.5M From Subsidies, Saved Nearly $10B; Ties High Insurer Pricing To Unauthorized Enrollments
  • [H2] Trump Transition
  • [H2] Top Story
  • [H2] Concerns Mount Over MA Among Rural Providers, Patient Advocates  
  • [H2] MedPAC Discusses Preliminary Analyses Of MA Network Participation Rates, Mid-Year Changes
  • [H2] Drug Pricing Deals In Spotlight
  • [H2] BALANCE Model RFA Breaks Down GLP-1 Coverage Criteria For States, Part D Plans  
  • [H2] Senate Dems Ask How Trump’s MFN Deals Mesh With GENEROUS Model
  • [H2] Makary, Prasad Outline Single-Trial Policy As New FDA Default  
  • [H2] FDA Plans Formal Launch Of ‘Plausible Mechanism’ Guidance
  • [H2] Document: Reactions To Califf Nomination  
  • [H2] Latest News
  • [H2] Focus On MA
  • [H2] INSIDE DRUG PRICING
  • [H2] INSIDE TELEHEALTH
  • [H2] INSIDE CMS
  • [H2] FDA WEEK
  • [H2] HEALTH EXCHANGE ALERT
  • [H2] MORE TOP STORIES
  • [H2] MORE NEWS
  • [H2] DOCUMENTS

Images

Nous avons trouvé 7 image(s) sur cette page Web.

Bien, la plupart ou la totalité de vos images possèdent un attribut alt

Ratio texte/HTML

Ratio : 25%

Idéal! le ratio de cette page texte/HTML est entre 25 et 70 pour cent.

Flash

Parfait, aucun contenu FLASH n'a été détecté sur cette page.

Iframe

Dommage, vous avez des Iframes sur vos pages Web, cela signifie que son contenu ne peut pas être indexé par les moteurs de recherche.

Réécriture d'URLs

Bien. Vos liens sont optimisés!

Tiret bas dans les URLs

Parfait! Aucuns soulignements détectés dans vos URLs.

Liens dans la page

Nous avons trouvé un total de 98 lien(s) dont 0 lien(s) vers des fichiers

Texte d'ancre Type Juice
Jump to Navigation Interne Passing Juice
Home Interne Passing Juice
Daily News Interne Passing Juice
Documents Interne Passing Juice
Health Insider Interne Passing Juice
Abortion Roundup Interne Passing Juice
Special Opioid Report Interne Passing Juice
Look Ahead 2026 Interne Passing Juice
Government Shutdown Interne Passing Juice
Post-Chevron Interne Passing Juice
Artificial Intelligence Interne Passing Juice
Coronavirus Interne Passing Juice
Abortion Interne Passing Juice
Health Equity Interne Passing Juice
Health Reform Debate Interne Passing Juice
Opioids Interne Passing Juice
Medicaid Interne Passing Juice
Medicare Interne Passing Juice
Rx Drugs Interne Passing Juice
Medical Devices Interne Passing Juice
Congress Interne Passing Juice
ACOs Interne Passing Juice
Emergency Response Interne Passing Juice
The Courts Interne Passing Juice
Transition 2025 Interne Passing Juice
21st Century Cures Interne Passing Juice
Budget Interne Passing Juice
Cybersecurity Interne Passing Juice
Food Safety Interne Passing Juice
Tobacco Interne Passing Juice
User Fees Interne Passing Juice
Waste and Fraud Interne Passing Juice
Latest News Interne Passing Juice
Documents Interne Passing Juice
Latest News Interne Passing Juice
Documents Interne Passing Juice
Inside TeleHealth Interne Passing Juice
About Us Interne Passing Juice
Privacy Policy Interne Passing Juice
Terms and Conditions Interne Passing Juice
Login Help Interne Passing Juice
SIGN UP Interne Passing Juice
Trump Admin To Launch Tariff Probe Into Foreign Drug Pricing Policies In Coming Months Interne Passing Juice
MAHA Memo Signals Strategic Retooling On Vaccine Messaging Ahead Of Midterms Interne Passing Juice
CCIIO Chief Says Fraud Crackdown Removed 1.5M From Subsidies, Saved Nearly $10B; Ties High Insurer Pricing To Unauthorized Enrollments Interne Passing Juice
Oz Wants Agentic AI Tools For All Medicare Beneficiaries Interne Passing Juice
Concerns Mount Over MA Among Rural Providers, Patient Advocates Interne Passing Juice
MedPAC Discusses Preliminary Analyses Of MA Network Participation Rates, Mid-Year Changes Interne Passing Juice
More Coverage → Interne Passing Juice
CMS To Make $50 Zepound, Wegovy Available Before BALANCE Launch Interne Passing Juice
BALANCE Model RFA Breaks Down GLP-1 Coverage Criteria For States, Part D Plans Interne Passing Juice
Senate Dems Ask How Trump’s MFN Deals Mesh With GENEROUS Model Interne Passing Juice
Makary, Prasad Outline Single-Trial Policy As New FDA Default Interne Passing Juice
FDA Plans Formal Launch Of ‘Plausible Mechanism’ Guidance Interne Passing Juice
Reactions To Califf Nomination Interne Passing Juice
E&C Health Subcommittee To Hold Hearing On Hospital Affordability Interne Passing Juice
VRBPAC Unanimously Approves Strains For Next Flu Vaccines Interne Passing Juice
Lilly Asks FDA To Recall GLP-1s Compounded With B12 Interne Passing Juice
FDA Guidance Aims To Streamline Biosimilar Development, Lower Costs Interne Passing Juice
Dem Committee Leaders Blast 2027 Exchange Rule Interne Passing Juice
Behavioral Health Providers Say Reimbursement Biggest Hurdle To AI Adoption Interne Passing Juice
Insurers: JEC’s Claim MA Overpayments Hike Premiums Uses Skewed MedPAC Data Interne Passing Juice
Aetna To Pay 117M To Resolve MA Plans’ Alleged FCA Violations Related To Upcoding Interne Passing Juice
Beneficiary Advocates Circulate Letter Asking Congress To Protect HCBS Interne Passing Juice
Medical Orgs Sue To Fend Off FTC’s Gender-Affirming Care Investigation Interne Passing Juice
FDA Advisor Touts Approach Tailoring Regulation To Specific AI Use Interne Passing Juice
CMS Adds Digital Identification To Medicare.gov, Touts High Uptake Interne Passing Juice
Novo Nordisk Confident It Will Resolve GLP-1 Warning Letter, Says Production Not Affected Interne Passing Juice
NCPA: 22% Of Pharmacies Going 28+ Days Without MFP Drug Refunds Interne Passing Juice
CMS’ ‘Emmy’ Medicaid Work Req App Awaits Additional Policy Guidance Interne Passing Juice
Safe Medicines Group Calls For Expansion Of FDA Regs After HIMS Ads Interne Passing Juice
INSIDE CMS Interne Passing Juice
Public Citizen To Push Compulsory Licensing If Pfizer Withholds Drugs From France Interne Passing Juice
NSA Implementation Fraught With IDR Issues Interne Passing Juice
FDA WEEK Interne Passing Juice
Hawley Again Attacks Mifepristone With Bill To Ban Use For Abortion Interne Passing Juice
RFK Jr. Critics Form Alternative Autism Panel As HHS Cancels IACC Meeting Interne Passing Juice
CMS Sends States First Round Of Federal Medicaid Work Req Funding Interne Passing Juice
CMS Gives States Two Options To Transition To Six-Month Medicaid Eligibility Checks Interne Passing Juice
Rare Disease, Vaccine Stakeholders Hope For Post-Prasad FDA Turnaround Interne Passing Juice
Clinicians Call For Public FDA Correction On Past Leucovorin Autism Claims Interne Passing Juice
FDA Leucovorin Approval Raises Concerns About Reliance On Case Reports Interne Passing Juice
FDA Gives Companies 7 Years To Prepare For Drug Code Update Interne Passing Juice
MAHA Conference Revives Vaccine-Autism Claims Despite GOP Push To Reframe Health Agenda Interne Passing Juice
Prasad Out At FDA, Turning Critics’ Focus Back To Makary Interne Passing Juice
New Eli Lilly Platform To Expand Obesity Drug Options For Employers Interne Passing Juice
House Members: HHS Must Address NIH Advisory Council Vacancies Interne Passing Juice
Food Policy Experts Warn Of State Patchwork On Ultra-Processed Food Interne Passing Juice
Novo Nordisk Set To Launch New 340B Claims Data Requirements In April Interne Passing Juice
SEC Filings Disclose Details Of TrumpRx Pricing Deals Interne Passing Juice
PCMA Op-Ed: Trump Promised Lower Drug Prices. Here's How Congress Virtually Guaranteed The Opposite Interne Passing Juice
Comments On 2027 Medicare Advantage Advance Notice Interne Passing Juice
NCPA Launches Multi-Million-Dollar National Ad Campaign To Promote Independent Pharmacies Interne Passing Juice
The Vitals Interne Passing Juice
Inside Drug Pricing Interne Passing Juice
About Inside Health Policy Interne Passing Juice
Advertising on Inside Health Policy Interne Passing Juice
About Inside Washington Publishers Externe Passing Juice

Mots-clefs

Nuage de mots-clefs

policy news cms pricing drug march health inside fda medicare

Cohérence des mots-clefs

Mot-clef Contenu Titre Mots-clefs Description Niveaux de titre
health 24
fda 19
inside 18
drug 15
policy 12

Ergonomie

Url

Domaine : insidehealthpolicy.com

Longueur : 22

Favicon

Génial, votre site web dispose d'un favicon.

Imprimabilité

Génial. L'impression est optimisée grâce aux styles CSS.

Langue

Bien. Votre langue est : en.

Dublin Core

Cette page ne profite pas des métadonnées Dublin Core.

Document

Doctype

Doctype manquant

Encodage

Parfait. Votre charset est UTF-8.

Validité W3C

Erreurs : 0

Avertissements : 0

E-mail confidentialité

Attention! Au moins une adresse e-mail a été trouvée en texte clair. Utilisez une protection anti-spam gratuite pour cacher vos e-mails aux spammeurs.

HTML obsolètes

Génial! Nous n'avons pas trouvé de balises HTML obsolètes dans votre code.

Astuces vitesse

Excellent, votre site n'utilise pas de tableaux imbriqués.
Mauvais, votre site web utilise des styles css inline.
Mauvais, votre site web contient trop de fichiers CSS (plus de 4).
Mauvais, votre site web contient trop de fichiers javascript (plus de 6).
Parfait : votre site tire parti de gzip.

Mobile

Optimisation mobile

Icône Apple
Méta tags viewport
Contenu FLASH

Optimisation

Sitemap XML

Votre site web dispose d’une sitemap XML, ce qui est optimal.

https://insidehealthpolicy.com/sitemap.xml

Robots.txt

https://insidehealthpolicy.com/robots.txt

Votre site dispose d’un fichier robots.txt, ce qui est optimal.

Mesures d'audience

Manquant

Nous n'avons trouvé aucun outil d'analytics sur ce site.

Un outil de mesure d'audience vous permet d'analyser l’activité des visiteurs sur votre site. Vous devriez installer au moins un outil Analytics. Il est souvent utile d’en rajouter un second, afin de confirmer les résultats du premier.

PageSpeed Insights

Dispositif
Les catégories

Free SEO Testing Tool

Free SEO Testing Tool est un outil gratuit de référencement qui vous aidera à analyser vos pages web